bf/NASDAQ:APLS_icon.jpeg

NASDAQ:APLS

Apellis Pharmaceuticals, Inc.

  • Stock

USD

Last Close

38.72

30/08 20:00

Market Cap

4.54B

Beta: 1.22

Volume Today

592.31K

Avg: 1.91M

PE Ratio

−13.43

PFCF: −12.54

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
250.65M
-
66.56M
73.44%
75.42M
13.31%
396.59M
425.83%
cost of revenue
50.77M
-
127.92M
151.98%
288.02M
125.14%
25.05M
91.30%
5.20M
79.24%
5.64M
8.38%
60.21M
968.38%
gross profit
-50.77M
-
-127.92M
151.98%
-288.02M
125.14%
225.60M
178.33%
61.36M
72.80%
69.79M
13.73%
336.38M
382.01%
selling and marketing expenses
-1.70M
-
general and administrative expenses
1.71M
-
2.91M
70.46%
6.36M
118.58%
4.30M
32.30%
10.46M
143.12%
22.64M
116.37%
67.05M
196.15%
139.40M
107.92%
176.77M
26.81%
277.16M
56.79%
500.81M
80.69%
selling general and administrative expenses
1.71M
-
2.91M
70.46%
6.36M
118.58%
4.30M
32.30%
10.46M
143.12%
22.64M
116.37%
67.05M
196.15%
139.40M
107.92%
176.77M
26.81%
277.16M
56.79%
499.11M
80.08%
research and development expenses
2.32M
-
8.38M
261.61%
13.73M
63.86%
22.98M
67.36%
40.30M
75.40%
105.29M
161.23%
220.97M
109.88%
299.92M
35.73%
420.87M
40.33%
387.24M
7.99%
354.39M
8.48%
other expenses
68.00K
-
62.46K
8.15%
6.28K
89.94%
157.71K
2,409.63%
11.54K
92.68%
-110.76K
1,059.61%
-175.31K
58.29%
-501K
185.77%
1.36M
371.86%
-288K
121.15%
-727K
152.43%
cost and expenses
4.03M
-
11.29M
180.28%
20.09M
77.85%
27.28M
35.82%
50.77M
86.08%
127.92M
151.98%
288.02M
125.14%
464.37M
61.23%
602.84M
29.82%
670.03M
11.15%
913.71M
36.37%
operating expenses
4.03M
-
11.29M
180.28%
20.09M
77.85%
27.28M
35.82%
50.77M
86.08%
127.92M
151.98%
288.02M
125.14%
439.32M
52.53%
597.64M
36.04%
664.40M
11.17%
853.50M
28.46%
interest expense
-96.92K
-
2.51M
2,692.95%
5.28M
110.29%
29.94M
466.49%
13.24M
55.77%
32.63M
146.40%
29.58M
9.33%
ebitda
-4.02M
-
-11.29M
180.56%
6.40M
156.69%
-27.28M
526.36%
-50.60M
85.47%
-125.07M
147.18%
-282.84M
126.14%
-209.43M
25.96%
-533.00M
154.51%
-584.50M
9.66%
-515.42M
11.82%
operating income
-4.03M
-
-11.29M
180.28%
-46.57M
312.36%
-27.28M
41.42%
-50.77M
86.08%
-127.92M
151.98%
-288.02M
125.14%
-213.73M
25.79%
-536.28M
150.92%
-594.61M
10.88%
-517.12M
13.03%
depreciation and amortization
6.26K
-
6.59K
5.25%
52.97M
803,236.37%
11.94K
-
2.94M
24,495.91%
5.17M
76.23%
4.30M
16.88%
3.27M
23.91%
10.11M
209.08%
1.70M
83.15%
total other income expenses net
68.00K
-
62.46K
8.15%
-26.48M
42,495.36%
157.71K
100.60%
-142.15K
190.14%
-25.25K
82.24%
-16.69M
66,007.01%
-129.30M
674.67%
-209.72M
62.20%
-56.89M
72.87%
-9.38M
83.52%
income before tax
-3.96M
-
-11.23M
183.52%
-46.52M
314.14%
-27.12M
41.69%
-51.01M
88.04%
-127.50M
149.97%
-304.71M
138.98%
-343.03M
12.58%
-746.00M
117.47%
-651.50M
12.67%
-526.50M
19.19%
income tax expense
-443.34K
-
-26.54M
5,885.67%
250.61K
-
-533.32K
312.81%
5.11M
1,058.01%
1.84M
63.89%
352K
80.92%
669K
90.06%
2.13M
218.68%
net income
-3.96M
-
-10.79M
172.33%
-46.52M
331.16%
-27.12M
41.69%
-51.01M
88.04%
-127.50M
149.97%
-309.82M
142.99%
-344.87M
11.32%
-746.35M
116.41%
-652.17M
12.62%
-528.63M
18.94%
weighted average shs out
18.09M
-
18.09M
0%
18.09M
0%
18.09M
0%
13.87M
23.33%
54.40M
292.16%
62.23M
14.40%
75.16M
20.79%
84.42M
12.32%
106.11M
25.70%
118.68M
11.84%
weighted average shs out dil
18.09M
-
18.09M
0%
18.09M
0%
18.09M
0%
13.87M
23.33%
54.40M
292.16%
62.23M
14.40%
75.16M
20.79%
84.42M
12.32%
106.11M
25.70%
118.68M
11.84%
eps
-0.22
-
-0.60
172.73%
-2.57
328.33%
-1.50
41.63%
-3.68
145.33%
-2.34
36.41%
-4.98
112.82%
-4.59
7.83%
-8.84
92.59%
-6.15
30.43%
-4.45
27.64%
epsdiluted
-0.22
-
-0.60
172.73%
-2.57
328.33%
-1.50
41.63%
-3.68
145.33%
-2.34
36.41%
-4.98
112.82%
-4.59
7.83%
-8.84
92.59%
-6.15
30.43%
-4.45
27.64%

All numbers in USD (except ratios and percentages)